Scopus
YÖKSİS DOI Eşleşti
SJR Q4
EVALUATION OF THE RELATIONSHIP BETWEEN MEDICAL NUTRITION TREATMENT, PENTRAXIN-3, HSCRP AND BODY COMPOSITION ANALYSIS IN TYPE 2 DIABETIC PATIENTS
Acta Endocrinologica · Nisan 2023
Özet
Objective. Medical Nutrition Therapy (MNT) is important in the treatment and regulation of diabetic patients. In this study, it was aimed to evaluate the effects of medical nutrition therapy on Pentraxin-3, hsCRP and body composition analysis in Type 2 diabetes patients (DM). Methods. This study included 160 individuals who were admitted and diagnosed with Type 2 DM. Laboratory, clinical, anthropometric and body composition parameters were obtained 3 months after baseline evaluation of the patients and the MNT was given by the dietitian. Results. After 3 months MNT, weight, body mass index, waist circumference, body fat weight, body fat ratio and visceral fat area (p<0.001), glucose (p<0.001), insulin (p=0.033), HOMA index (p=0.004), HbA1c (p<0.001), total cholesterol (p=0.001), LDL (p=0.008), ALT (p<0.001) and hsCRP (p<0.001) levels were significantly lower than they were before MNT. There wasn’t significant difference in triglyceride (p=0.509), HDL (p=0.079), Pentraxin-3 (p=0.706) levels and waist-to-hip ratio (p=0.802). The level of Framingham risk score after MNT was significantly lower (p<0.001). Conclusion. In this study, it was cocluded that MNT, applied to patients with Type 2 DM decreased cardiovascular risk and inflammation, contributed to the maintenance of glycemic control, and a significantly improved the body composition.
YÖKSİS Kayıtları
Evaluation of the Relationship between Medical Nutrition Treatment, PENTRAXIN-3, HSCRP and Body Composition Analysis in Type 2 Diabetic Patients
ACTA Endocrinologica Foundation · 2023 SCI-Expanded
Prof. Dr. HÜSAMETTİN VATANSEV →
Evaluation of the Relationship between Medical Nutrition Treatment, PENTRAXIN-3, HSCRP and Body Composition Analysis in Type 2 Diabetic Patients
ACTA Endocrinologica Foundation · 2023 SCI
Prof. Dr. KAMİLE MARAKOĞLU →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 6 kaydı bulundu.
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 6 kaydı bulundu.
Diabetes Mellitus with Left Transverse and Sigmoid Sinus Thrombosis Extending into the Internal Jugular Vein
2011 ISSN: 18410987 SCI-Expanded
Prof. Dr. HALUK GÜMÜŞ →
Evaluation Of Urinary Iodine Levels and Thyroid Function Tests in Pregnant Women And Their Infants
2017 ISSN: 18410987 SSCI
Prof. Dr. KAMİLE MARAKOĞLU →
New Biomarkers to Predict Cardiovascular Risk in Patients with Adrenal Incidentaloma; Irisin and Nesfatin-1
2022 ISSN: 1841-0987 SCI-Expanded Q4
Prof. Dr. FATMA HÜMEYRA YERLİKAYA AYDEMİR →
New Biomarkers to Predict Cardiovascular Risk in Patients with Adrenal Incidentaloma; Irisin and Nesfatin-1
2022 ISSN: 1841-0987 SCI-Expanded Q4
Prof. Dr. FATMA HÜMEYRA YERLİKAYA AYDEMİR →
Evaluation of the Relationship between Medical Nutrition Treatment, PENTRAXIN-3, HSCRP and Body Composition Analysis in Type 2 Diabetic Patients
2023 ISSN: 1841-0987 SCI Q4
Prof. Dr. KAMİLE MARAKOĞLU →
Evaluation of the Relationship between Medical Nutrition Treatment, PENTRAXIN-3, HSCRP and Body Composition Analysis in Type 2 Diabetic Patients
2023 ISSN: 1841-0987 SCI-Expanded Q4
Prof. Dr. HÜSAMETTİN VATANSEV →
Makale Bilgileri
Dergi
Acta Endocrinologica
Toplam Atıf
0 atıf
· Scopus
ISSN18410987
Yayın TarihiNisan 2023
Cilt / Sayfa19 · 169-177
Scopus ID2-s2.0-85175188722
Kurumlar
Selçuk Üniversitesi
Selçuklu Turkey
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
Acta Endocrinologica
Q4
OA
SJR Skoru0,288
H-Index24
YayıncıActa Endocrinologica Foundation
ÜlkeRomania
Endocrine and Autonomic Systems (Q4)
Endocrinology (Q4)
Endocrinology, Diabetes and Metabolism (Q4)